Drug Profile
DY 301
Alternative Names: Iodine lecithin; L-LBI; Licorice-lecithin bound iodine; Liquorice-lecithin bound iodineLatest Information Update: 27 Dec 2000
Price :
$50
*
At a glance
- Originator Daiichi Pharmaceutical
- Developer Daiichi Pharmaceutical; Nagasaki University School of Medicine; Toho University School of Medicine
- Class Antiasthmatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 27 Dec 2000 Discontinued-Clinical for Asthma in Japan (PO)
- 05 Aug 1996 Investigation in Asthma in Japan (PO)